FDA Suspends Certain Trials of Merck’s Keytruda

The FDA suspended two clinical trials and a portion of a third testing Merck’s Keytruda as a treatment for blood cancer, after more patients receiving the drug died than those receiving other treatments. All images and written content is property of the listed RSS FEED if you would like more on this story and images please click the listed feed. http://www.wsj.com/xml/rss/3_7014.xml

Leave a Reply